Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center - Lax, Naama; Davidovits, Miriam; Chodick, Gabriel; Bernfeld, Yael; Peled, Orit (Frontiers in Pharmacology, 2025)